Scissortail Wealth Management »

Halozyme Therapeutics shares owned by Scissortail Wealth Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Scissortail Wealth Management from 13F filings

Historical chart of Scissortail Wealth Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Scissortail Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Scissortail Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $209k 2.9k 73.34
2023-03-31 $7.6M 2.9k 2614.68
2022-06-30 $131k 3.3k 40.25
2021-12-31 $131k 3.3k 40.25

More positions owned by Scissortail Wealth Management

Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr S&p 500 Grwt Etf (IVW)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Apple (AAPL)
Ishares Tr S&p 500 Val Etf (IVE)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Ibonds 25 Trm Ts (IBTF)
Blackrock Etf Trust Ii Ishares Flexible (BINC)
Ishares Tr Ibonds 26 Trm Ts (IBTG)
Broadcom (AVGO)
Wal-Mart Stores (WMT)
Microsoft Corporation (MSFT)
Ishares Tr Ibonds 28 Trm Ts (IBTI)

View all positions for Scissortail Wealth Management

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Arrowstreet Capital, Limited Partnership
Invesco
UBS Group
Snyder Capital Management
D. E. Shaw & Co
Geode Capital Management
Dimensional Fund Advisors
Alliancebernstein
Morgan Stanley
Macquarie Group
Federated Investors
Congress Asset Management

View all funds holding Halozyme Therapeutics